Comments Subscribe to Personal Liberty News Feed Subscribe to Personal Liberty
 

Chemo Makes Cancer Worse

November 27, 2012 by  

In the case of cancer, the cure is usually worse than the disease. Practitioners of alternative method understand this. Perhaps this paradigm will one day be understood by conventional medical doctors.

According to a study published in the journal Nature Medicine, researchers have discovered that chemotherapy is actually a catalyst for cancer-cell growth. In men suffering from prostate cancer receiving chemotherapy, researchers found DNA damage in healthy cells. These cells secreted a protein called WNT16B that boosts cancer cell survival.

“The increase in WNT16B was completely unexpected,” said study co-author Peter Nelson of the Fred Hutchinson Cancer Research Center. “WNT16B, when secreted, would interact with nearby tumor cells and cause them to grow, invade, and importantly, resist subsequent therapy.”

Nelson and his team then confirmed their findings in breast and ovarian cancer tumors. He went on to say the results could lead to research for new and improved methods of treatment.

Nelson did not point toward known effective natural cancer treatment options like turmeric and ginger, which have consistently been found to shrink tumors and combat the spread of cancer cells. He did not mention vitamin D supplementation, which has been shown to be an effective treatment for many cancers and other diseases. And he did not mention that cancer sufferers should forgo all types of sugars, which feed cancer like dry timber feeds a forest fire.

Of course, using natural supplements and avoiding sugars does not feed the pharmaceutical industry and the medical industrial complex.

Bob Livingston

is an ultra-conservative American and author of The Bob Livingston Letter™, founded in 1969. Bob has devoted much of his life to research and the quest for truth on a variety of subjects. Bob specializes in health issues such as nutritional supplements and alternatives to drugs, as well as issues of privacy (both personal and financial), asset protection and the preservation of freedom.

Facebook Conversations

Join the Discussion:
View Comments to “Chemo Makes Cancer Worse”

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.

Is there news related to personal liberty happening in your area? Contact us at newstips@personalliberty.com

  • Elda

    I have wondered about this. I know of someone that had a blood test one day that was clear of any abnormalities and a few days later showing blood cancer. They were wisked away to a cancer clinic and soon died from the distruction the chemo caused. I wonder how long they would have lived had they not had the second blood test saying they were riddled with cancer. I think they would have lived at least a couple years. They were very healthy other wise.

    • bakershouse77@gmail.com

      This is absolutely the case. Every time I have known someone that has been diagnosed with cancer, they looked great up until the day they started the old “standard treatment”. The new studies being done today are showing without a shadow of a doubt, that chemo actually turns cancer stem cells into factories operating on overdrive…. Anyone in they’re right minds in this day and age, would stay as far away from conventional cancer treatment as they possibly could…. There are far more effective natural treatments available today, with little to no side effects… And that is backed up by current science.. We will look back on today’s conventional cancer treatment and liken it to the similar barbaric medicine of the late 1800′s…

  • Harold Olsen

    Having had cancer myself, I’m not sure I agree with the idea that chemo makes cancer worse. I will say this though, it sure makes you sick as hell. When I started treatment it was outpatient. However, I got so sick, they put me in the hospital overnight for my treatment. That was 27 years ago. Of course, if Obamacare had been around then, I’d be dead now.

  • http://twitter.com/jesichashope Jesicha`s Hope (@jesichashope)

    Cutting, burning and poisoning in the name of healthcare is not the solution. There are the lucky ones that survive not only the treatment but the cancer as well, these are indeed the lucky ones. Most are not so lucky and will have the cancer back in a much more aggressive state than before.
    There are true alternatives that have been used for years in other countries, though they do not make a doctor rich, they do make the patient well. Here in the US it is all about the money. To make a point, most doctors will take themselves or their loved one outside the US if they are diagnosed with cancer; a recent survey of oncologists found over 90 percent said they would not take chemo or radiation but would instead leave the US where cures are available.Says something for the dedication our doctors have to healing us, and how much confidence they have in what they practice.
    At Jesicha’s Hope we open doors for many modalities, we understand the desperation and fear in such a diagnosis and we want to end the suffering. Hope is real. Today we have a wonderful treatment used for 18 years under controlled research and is now available worldwide, you can find it on our site as well. We are available seven days a week because we know cancer does not wait. It is time we take control of our own health and that of our loved ones. It is our right. If you know someone or you are suffering yourself, take control, its your life. Find us at jesichashope dot org and get the resources and support you deserve. Its all up to us to help each other.

    • Lisa G. Herrmann

      Greetings,
      I was diagnosed with Stage 4 ovarian cancer in March, 2012, and have subsequently gone through eight Montserrat of he’ll. I am currently at the Mayo clinic MiNnesota, but am again sceptical about the conventional treatment course.I would-be willing to traveling distance to explore alternative approaches to treatment that will not result in my rapid and certain demise. Any suggestions would-be deeply appreciated.
      Thanks,
      Lisa

      *please forgive my new tablet’s grammatical idiosyncrasies…

      • http://twitter.com/jesichashope Jesicha`s Hope (@jesichashope)

        There are alternative treatments for cancer that can and will not only improve ones condition but will resolve the cancer completely. One must always understand when going into a non-invasive treatment, coming from the conventional treatments, the body has sustained damage from the chemo and radiation [and surgery] therefore the body is compromised. Immune systems are greatly hit when taking chemo or radiation; all non-invasive treatments do not damage the immune system but also need to try to repair the immune system while trying to fight the cancer. Chemo does not heal, some are lucky, but the majority will lose quality of life and in the end find the cancer return, stronger, more aggressive than ever. If you want resources or consultations of a doctor with known results that will give you hope for cancer resolve; please contact me at jesichashope dot org I am available seven days a week, because we know cancer does not wait or take weekends off. Your cancer, anyone’s cancer can be beat, life is an option; you have to look beyond the conventional box we have been put in. Believe in Life!

      • amadea

        Lisa, Stop in Abundant Chi Community Acupuncture on 2nd Street and 6th Ave.

  • Coalminer

    Science News:

    Leukemia Patients Remain in Remission More Than Two Years After Engineered T Cell Therapy
    Dec. 9, 2012 — Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients’ tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania. Penn Medicine researchers will present the latest results of the trial December 10 at the American Society of Hematology’s Annual Meeting and Exposition.

    ——————————————————————————–

    Share This:

    7

    Related Ads:
    •Leukemia Cancer
    •Stem Cells Uses
    •Brain Tumor
    •Drug Treatment

    See Also:

    Health & Medicine
    •Leukemia
    •Stem Cells
    •Brain Tumor
    •Lymphoma
    •Immune System
    •Cancer

    Reference
    •Bone marrow transplant
    •Leukemia
    •Stem cell treatments
    •Transplant rejection

    The clinical trial participants, all of whom had advanced cancers, included 10 adult patients with chronic lymphocytic leukemia treated at the Hospital of the University of Pennsylvania (HUP) and two children with acute lymphoblastic leukemia treated at the Children’s Hospital of Philadelphia. Two of the first three patients treated with the protocol at HUP — whose cases were detailed in the New England Journal of Medicine and Science Translational Medicine in August 2011 — remain healthy and in full remissions more than two years after their treatment, with the engineered cells still circulating in their bodies. The findings reveal the first successful and sustained demonstration of the use of gene transfer therapy to turn the body’s own immune cells into weapons aimed at cancerous tumors.

    “Our results show that chimeric antigen receptor modified T cells have great promise to improve the treatment of leukemia and lymphoma,” says the trial’s leader, Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in Penn’s Abramson Cancer Center. “It is possible that in the future, this approach may reduce or replace the need for bone marrow transplantation.”

    The results pave the way for a potential paradigm shift in the treatment of these types of blood cancers, which in advanced stages have the possibility of a cure only with bone marrow transplants. That procedure requires a lengthy hospitalization and carries at least a 20 percent mortality risk — and even then offers only a limited chance of cure for patients whose disease has not responded to other treatments.

    The protocol for the new treatment involves removing patients’ cells through an apheresis process similar to blood donation, and modifying them in Penn’s cell and vaccine production facility. Scientists there reprogram the patients’ T cells to target tumor cells through a gene modification technique using a HIV-derived lentivirus vector. The vector encodes an antibody-like protein, called a chimeric antigen receptor (CAR), which is expressed on the surface of the T cells and designed to bind to a protein called CD19.

    The modified cells are then infused back into the patient’s body following lymphodepleting chemotherapy. Once the T cells start expressing the CAR, they focus all of their killing activity on cells that express CD19, which includes CLL and ALL tumor cells, and normal B cells. All of the other cells in the patient that do not express CD19 are ignored by the modified T cells, which limits systemic side effects typically experienced during traditional therapies.

    In addition to initiating the death of the cancer cells, a signaling molecule built into the CAR also spurs the cell to produce cytokines that trigger other T cells to multiply — building a bigger and bigger army until all the target cells in the tumor are destroyed.

    In the patients who experienced complete remissions after treatment, the CAR T cells exhibited vigorous proliferation after infusion, with the most robust expansion activity usually occurring between 10 and 31 days after infusion. Each of these patients developed a cytokine release syndrome — marked by fever, nausea, hypoxia and low blood pressure — which doctors treated when needed with the anti-cytokine agent tocilizumab. Ultimately, the modified T cell treatment eradicated large amounts of tumor in these patients.

    Tests of patients with complete responses also show that normal B cells have been eliminated along with their tumors. Since these cells are important for the body’s immune system to fight infection, the patients now are receiving regular gamma globulin treatments as a preventive measure. No unusual infections have been observed.

    In August 2012, the University of Pennsylvania and Novartis announced an exclusive global research and licensing agreement to further study and commercialize these novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies. As part of the transaction, Novartis acquired exclusive rights from Penn to CART-19, the therapy that was the subject of this clinical trial and which is now known as CTL019. Together, Penn and Novartis will build a first-of-its-kind Center for Advanced Cellular Therapies (CACT) in Philadelphia, which will be devoted to the discovery, development and manufacturing of adoptive T cell immunotherapies through a joint research and development program led by scientists and clinicians from Penn and Novartis. Patients seeking information about this trial may visit http://www.penncancer.org/Tcelltherapy/.

    Three abstracts about the new research will be presented during the ASH meeting. David Porter, MD, director of Blood and Marrow Transplantation in the Abramson Cancer Center, will give an oral presentation of Abstract #717 on Dec. 10. Michael Kalos, PhD, director of the Translational and Correlative Studies Laboratory at Penn, will give an oral presentation on Abstract #756 on Dec. 10. Stephan Grupp, MD, PhD, director of Translational Research in the Center for Childhood Cancer Research at the Children’s Hospital of Philadelphia, will present a poster of Abstract #2604 on Dec. 9.

    • Coalminer

      What do you think?

Bottom
close[X]

Sign Up For Personal Liberty Digest™!

PL Badge

Welcome to PersonalLiberty.com,
America's #1 Source for Libertarian News!

To join our group of freedom-loving individuals and to get alerts as well as late-breaking conservative news from Personal Liberty Digest™...

Privacy PolicyYou can opt out at any time. We protect your information like a mother hen. We will not sell or rent your email address to anyone for any reason.